Position in MRK
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,584,919
+$101,864 QoQ
Shares Held
12,334
+0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,749
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DELTA ASSET MANAGEMENT LLC/TN holds $27,667,664 across 14 Drug Manufacturers - General names. MRK ranks #5 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
40,142 | $10,194,863 | |
| 2 | ABBV |
AbbVie Inc.
|
30,429 | $7,657,153 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
75,264 | $4,336,711 | |
| 4 | PFE |
Pfizer Inc
|
105,462 | $2,539,524 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
12,334 | $1,584,919 | |
| 6 | LLY |
ELI LILLY & Co
|
671 | $804,817 | |
| 7 | AMGN |
Amgen Inc
|
999 | $361,757 | |
| 8 | GSK |
GSK plc
|
2,138 | $112,073 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,584,919 | 12,334 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,483,055 | 12,329 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,293,434 | 12,288 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,085,047 | 12,928 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,021,401 | 12,903 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,171,637 | 13,053 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,419,579 | 14,270 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,629,131 | 14,346 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,778,387 | 14,365 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,915,914 | 14,520 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,593,872 | 14,620 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,541,676 | 14,975 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,727,965 | 14,975 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,595,850 | 15,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,612,214 | 14,531 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,271,820 | 14,768 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,389,613 | 15,242 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,322,646 | 16,120 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,239,268 | 16,170 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,199,056 | 15,964 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $1,241,520 | 15,964 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,230,665 | 15,964 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $1,353,707 | 16,549 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,372,740 | 16,549 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $1,280,894 | 16,564 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $1,282,127 | 16,664 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||